Lawsuits in a multidistrict litigation (MDL) alleging birth defects from anti-nausea drug Zofran have increased substantially according to a Reuters analysis of statistics from the U.S. Judicial Panel on Multidistrict litigation. Zofran, known chemically as ondansetron, is manufactured by GlaxoSmithKline. It is approved to treat nausea for patients undergoing chemotherapy and following surgery, and works by blocking serotonin in the areas of the brain that trigger nausea and vomiting. From 2002 to 2004, GlaxoSmithKline began marketing Zofran for the treatment of morning sickness in pregnant women, an indication the drug was not approved to treat. Doctors have the discretion of ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.